These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3415285)

  • 41. Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry.
    Fine JD; Johnson LB; Weiner M; Suchindran C
    Laryngoscope; 2007 Sep; 117(9):1652-60. PubMed ID: 17762793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generalized atrophic benign epidermolysis bullosa--poor prognosis associated with chronic renal failure.
    Woo HJ; Lee JH; Kim SC; Kim CW; Kim TY
    Clin Exp Dermatol; 2000 May; 25(3):212-4. PubMed ID: 10844498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C;
    Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastrointestinal complications of epidermolysis bullosa in children.
    Freeman EB; Köglmeier J; Martinez AE; Mellerio JE; Haynes L; Sebire NJ; Lindley KJ; Shah N
    Br J Dermatol; 2008 Jun; 158(6):1308-14. PubMed ID: 18363753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Large melanocytic nevi in hereditary epidermolysis bullosa.
    Bauer JW; Schaeppi H; Kaserer C; Hantich B; Hintner H
    J Am Acad Dermatol; 2001 Apr; 44(4):577-84. PubMed ID: 11260529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephro-urological complications of epidermolysis bullosa in paediatric patients.
    Chan SM; Dillon MJ; Duffy PG; Atherton DJ
    Br J Dermatol; 2007 Jan; 156(1):143-7. PubMed ID: 17199581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size.
    Fine JD; Johnson LB; Weiner M; Suchindran C
    Br J Dermatol; 2005 May; 152(5):1009-14. PubMed ID: 15888161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nutrition management of patients with epidermolysis bullosa.
    Birge K
    J Am Diet Assoc; 1995 May; 95(5):575-9. PubMed ID: 7722193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidermolysis bullosa letalis (Herlitz disease): a case report.
    Singalavanija S; Phuvichit B; Palungwachira P
    J Med Assoc Thai; 1994 Feb; 77(2):103-7. PubMed ID: 7798834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vegetative dystrophic epidermolysis bullosa. Urogenital manifestations and treatment with hydantoin].
    Woscoff A; Paz A; Abulafia J; Jaimovich L; Grinspan D
    Med Cutan Ibero Lat Am; 1984; 12(2):129-35. PubMed ID: 6374321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapy of esophageal stenoses in recessive epidermolysis bullosa dystrophica].
    Weidauer H; Feurle GE; Baldauf G; Anton-Lamprecht I
    Laryngol Rhinol Otol (Stuttg); 1985 Oct; 64(10):522-6. PubMed ID: 4068856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antenatal diagnosis of hereditary epidermolysis bullosa].
    Blanchet-Bardon C; Dumez Y; Nazzaro V; Mimoz C; Puissant A
    Ann Dermatol Venereol; 1987; 114(4):525-39. PubMed ID: 3619299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects.
    Scheinfeld N
    Dermatol Online J; 2003 Aug; 9(3):6. PubMed ID: 12952753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa.
    Mallipeddi R; Keane FM; McGrath JA; Mayou BJ; Eady RA
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):521-6. PubMed ID: 15324385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prenatal diagnosis for epidermolysis bullosa: a study of 144 consecutive pregnancies at risk.
    Pfendner EG; Nakano A; Pulkkinen L; Christiano AM; Uitto J
    Prenat Diagn; 2003 Jun; 23(6):447-56. PubMed ID: 12813757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Epidermolysis bullosa atrophicans gravis. Report of a therapeutic trial with dapsone].
    Krähe J; Galal O; Kordass U; Bornemann P
    Monatsschr Kinderheilkd; 1988 Mar; 136(3):140-2. PubMed ID: 3374498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collagen metabolism in two rare forms of epidermolysis bullosa.
    Kero M; Palotie A; Peltonen L
    Br J Dermatol; 1984 Feb; 110(2):177-84. PubMed ID: 6320858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter study.
    Lara-Corrales I; Mellerio JE; Martinez AE; Green A; Lucky AW; Azizkhan RG; Murrell DF; Agero AL; Kantor PF; Pope E
    Pediatr Dermatol; 2010; 27(3):238-43. PubMed ID: 20609141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.